News
Cerberus Therapeutics Appoints Dr. Michael Hodges to its Scientific Advisory Board
January 3, 2024
Cerberus Therapeutics Secures $5 Million Strategic Investment
December 5, 2023
Cerberus Therapeutics was awarded Novo Nordisk Golden Ticket
September 1, 2023
Cerberus Therapeutics Appoints Jim Weissman to its Board of Directors
May 15, 2023
Cerberus Therapeutics Appoints Dr. David Hafler to its Scientific Advisory Board
December 8, 2022
Cerberus Therapeutics was awarded Biogen 2022 Golden Ticket
December 1, 2022
Cerberus Therapeutics Appoints Dr. Michael L. Dougan to its Scientific Advisory Board
October 26, 2022
Cerberus Therapeutics was awarded the AbbVie-LabCentral Golden Ticket
May 1, 2022
Cerberus Therapeutics Secures $4mm in Seed Investment
December 8, 2021